Clinical Trials Browser

Phase 1 × INDUSTRY × indibulin × Clear all

NCT00591136 2012-07-19

Phase I Study of Indibulin in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00591292 2012-07-19

Phase I Study in Advanced Solid Tumors

Phase 1 Unknown

Neoplasms

NCT00591383 2012-07-19

Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Phase 1 Unknown

Neoplasms

NCT00591890 2012-07-19

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Phase 1 Completed

Advanced Cancer